MedTrace Logo

Cancer Control Following Polypectomy

NCT00591279 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2023-09-13

No results posted yet for this study

Summary

This study evaluates strategies for the surveillance of post-polypectomy patients for the control of bladder cancer

Conditions

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Mount Sinai Hospital, New York

    collaborator OTHER

  • Minneapolis Veterans Affairs Medical Center

    collaborator FED

  • Medical College of Wisconsin

    collaborator OTHER

  • St. Lukes hospital in Racine, Wiscousin

    collaborator UNKNOWN

  • Massachusetts General Hospital

    collaborator OTHER

  • Cedars-Sinai Medical Center

    collaborator OTHER

  • Valley Presbyterian Hospital

    collaborator OTHER

  • Memorial Sloan Kettering Cancer Center

    lead OTHER

Principal Investigators

  • Sidney Winawer, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1981-02-28
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00591279 on ClinicalTrials.gov